semaglutide
Ozempic
Novo Nordisk
$968/mo
Ozempic is brand-name semaglutide approved for adults with Type 2 diabetes. It is widely prescribed off-label for weight loss, particularly before Weg…
Every GLP-1 receptor agonist medication on the market — brand-name, compounded, and weight-loss-specific. Pricing, dosing, FDA approval, insurance coverage.
Ozempic is brand-name semaglutide approved for adults with Type 2 diabetes. It is widely prescribed off-label for weight loss, particularly before Weg…
Wegovy is the FDA-approved semaglutide product specifically indicated for chronic weight management. It carries a higher max dose (2.4 mg) than Ozempi…
Mounjaro is brand-name tirzepatide, a dual GIP/GLP-1 receptor agonist approved for Type 2 diabetes. Tirzepatide produced the largest weight-loss effec…
Zepbound is FDA-approved tirzepatide for chronic weight management. SURMOUNT-1 trial reported a mean ~22.5% body-weight reduction at 72 weeks at the h…
Compounded semaglutide is prepared by licensed compounding pharmacies (503A or 503B) for individual patients. Not FDA-approved as a finished drug. Apr…
Compounded tirzepatide is prepared by licensed compounding pharmacies on a per-patient basis. Not FDA-approved as a finished product. April 2026 FDA g…
Saxenda is daily liraglutide approved for chronic weight management in 2014, the original FDA-approved GLP-1 weight-loss product. Largely supplanted b…
Victoza is daily liraglutide approved for Type 2 diabetes — the same molecule as Saxenda at lower max dose. Generic liraglutide entered the U.S. marke…
Rybelsus is oral semaglutide for Type 2 diabetes. Convenient pill form, but strict dosing requirements (fasting, water only) and lower bioavailability…
Trulicity is once-weekly dulaglutide for Type 2 diabetes. Mid-tier weight-loss effect compared to semaglutide and tirzepatide.…